Reply

Affiliations

Comment

Charles A Hay et al. Arthritis Care Res (Hoboken). 2022 Jan.

. 2022 Jan;74(1):161-162.

doi: 10.1002/acr.24777. Epub 2021 Dec 22.

¹ Keele University, Newcastle, UK.
² Liverpool School of Tropical Diseases Liverpool, UK and Keele University, Newcastle, UK.

No abstract available

Comment on

Mortality in Patients With Gout Treated With Allopurinol: A Systematic Review and Meta-Analysis.
Hay CA, Prior JA, Belcher J, Mallen CD, Roddy E. Hay CA, et al. Arthritis Care Res (Hoboken). 2021 Jul;73(7):1049-1054. doi: 10.1002/acr.24205. Epub 2021 Jun 18. Arthritis Care Res (Hoboken). 2021. PMID: 32286732
All-cause mortality and allopurinol use: comment on the article by Hay et al.
Lai SW. Lai SW. Arthritis Care Res (Hoboken). 2022 Jan;74(1):161. doi: 10.1002/acr.24778. Arthritis Care Res (Hoboken). 2022. PMID: 34477329 No abstract available.

1. FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles AM, et al. 2020 American College of Rheumatology guideline for the management of gout. Arthritis Care Res (Hoboken) 2020;72:744-60.
1. Hui M, Carr A, Cameron S, Davenport G, Doherty M, Forrester H, et al. The British Society for Rheumatology guideline for the management of gout. Rheumatology (Oxford) 2017;56:e1-20.
1. Yang CY, Chen CH, Deng ST, Huang CS, Lin YJ, Chen YJ, et al. Allopurinol use and risk of fatal hypersensitivity reactions: a nationwide population-based study in Taiwan. JAMA Intern Med 2015;175:1550-7.